Skip to main content

Table 3 Risk factors for MACE

From: Effect of an increase in Lp(a) following statin therapy on cardiovascular prognosis in secondary prevention population of coronary artery disease

 

Univariate analysis

Multivariate analysis

HR (95%CI)

p

HR (95%CI)

p

Age

1.02 (1.003–1.05)

0.023

1.02 (1.002–1.05)

0.033

hs-CRP

1.03 (1.008–1.04)

0.003

1.02 (1.003–1.04)

0.020

On-statin LDL-C

1.47 (1.07–2.21)

0.018

1.45 (1.05–2.01)

0.024

Diabetes mellitus

1.73 (1.18–2.54)

0.005

1.69 (1.15–2.49)

0.008

  1. hs-CRP high sensitivity C-reactive protein, LDL-C low density lipoprotein cholesterol
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us